Education
About Us
Working with TipRanks
Follow Us
Health Catalyst (HCAT)
NASDAQ:HCAT
HCAT Stock Chart & Stats
$2.15
$0.34(4.94%)
At close: 4:00 PM EST
$2.15
$0.34(4.94%)
Day’s Range― - ―
52-Week Range$2.02 - $5.90
Previous CloseN/A
Volume315.36K
Average Volume (3M)508.95K
Market Cap
$152.07M
Enterprise Value$283.89M
Total Cash (Recent Filing)$91.54M
Total Debt (Recent Filing)$172.12M
Price to Earnings (P/E)―
Beta1.46
Next Earnings
Mar 03, 2026EPS Estimate
0.09Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.06
Shares Outstanding70,730,880
10 Day Avg. Volume532,773
30 Day Avg. Volume508,953
Financial Highlights & Ratios
PEG Ratio0.14
Price to Book (P/B)1.17
Price to Sales (P/S)1.39
P/FCF Ratio-231.38
Enterprise Value/Market Cap1.87
Enterprise Value/Revenue0.90
Enterprise Value/Gross Profit1.93
Enterprise Value/Ebitda-8.67
Forecast
1Y Price Target
$3.90Price Target Upside81.40% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering7
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Bookings And RetentionBookings modestly above internal targets and steady client retention indicate commercial momentum that could convert into increased platform revenue as sales opportunities close.
Capital Allocation And EfficiencyConcentrating capital on differentiated, high-value initiatives and targeted investment in India to improve utilization can reduce costs and enhance profitability.
Platform MigrationContinued migration of clients to the higher-margin Ignite platform can lift overall margins and support a return to revenue growth as migrations complete.
Bears Say
Budgetary Pressure On CustomersTightening hospital budgets, particularly if subsidy support is reduced, could limit customer spending on analytics solutions and weaken demand.
Legacy Client Spending DelaysMany legacy-platform clients may postpone discretionary investments until after migration to Ignite, causing revenue deferral and slower top-line growth.
Purchasing UncertaintyHealth systems re-evaluating purchasing decisions amid the platform transition may delay deal closings and reduce near-term revenue visibility.
Health Catalyst News
HCAT FAQ
What was Health Catalyst’s price range in the past 12 months?
Health Catalyst lowest stock price was $2.02 and its highest was $5.90 in the past 12 months.
What is Health Catalyst’s market cap?
Health Catalyst’s market cap is $152.07M.
When is Health Catalyst’s upcoming earnings report date?
Health Catalyst’s upcoming earnings report date is Mar 03, 2026 which is in 30 days.
How were Health Catalyst’s earnings last quarter?
Health Catalyst released its earnings results on Nov 10, 2025. The company reported $0.06 earnings per share for the quarter, missing the consensus estimate of $0.061 by -$0.001.
Is Health Catalyst overvalued?
According to Wall Street analysts Health Catalyst’s price is currently Undervalued.
Does Health Catalyst pay dividends?
Health Catalyst does not currently pay dividends.
What is Health Catalyst’s EPS estimate?
Health Catalyst’s EPS estimate is 0.09.
How many shares outstanding does Health Catalyst have?
Health Catalyst has 70,730,880 shares outstanding.
What happened to Health Catalyst’s price movement after its last earnings report?
Health Catalyst reported an EPS of $0.06 in its last earnings report, missing expectations of $0.061. Following the earnings report the stock price went down -5.614%.
Which hedge fund is a major shareholder of Health Catalyst?
Currently, no hedge funds are holding shares in HCAT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Health Catalyst Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$3.90 (81.40% Upside)
$3.90 (81.40% Upside)
Blogger Sentiment
Bullish
HCAT Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 405.3K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $128.2K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.3%
Last 30 Days ▼ 6.0%
Last 30 Days ▼ 6.0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-61.05%
12-Months-Change
Fundamentals
Return on Equity
-31.33%
Trailing 12-Months
Asset Growth
-27.79%
Trailing 12-Months
Company Description
Health Catalyst
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its offerings include data and analytics platform, a commercial-grade data and analytics platform for the healthcare sector; AI and data science, providing integration of AI into existing business intelligence tools, increasing analytics accuracy; population health management identifies improvement across the care continuum as well as actionable guidance for success and automated workflows; financial transformation providing costing and labor productivity insights and revenue capture; quality and safety improvement using clinical quality and patient safety data, analytics, and expert services; and national data ecosystem for thought leadership and mutual knowledge exchange to transform care delivery through next-gen insights. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is based in South Jordan, Utah.
HCAT Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call reflected a mix of positive financial results exceeding expectations and strategic operational successes, tempered by challenges in professional services revenue, retention pressures, and migration-related headwinds.View all HCAT earnings summariesHCAT Stock 12 Month Forecast
Average Price Target
$3.90
▲(81.40% Upside)
Technical Analysis
HealthStream
―
OptimizeRx
―
Evolent Health
―
SOPHiA GENETICS
―
Definitive Healthcare Corp
―
Ownership Overview
5.41% Insiders
16.73% Mutual Funds
2.99% Other Institutional Investors
63.13% Public Companies and
Individual Investors